Hodgkin's lymphoma, chemotherapy and exercise: hematological responses and physical performance
Year: 2016
Type: article
Study design: Case Report
Abstract: Hodgkin's lymphoma, chemotherapy and exercise: hematological responses and physical performanceIntroduction: Cancer is a multifactorial origin of disease, evolving from external stimuli and the inefficiency of the immune system. Hodgkin's Lymphoma (HL) is characterized by the presence of cells in Hodgkin and Reed-Sternberg with a stable incidence from 1 to 4 cases per 100,000 people / year. Chemotherapy, for use in treating patients with LH aims to eliminate malignant cells, but can also affect the benign cells and promote various side effects. The practice of physical exercise, concomitant to chemotherapy, might be a good strategy to mitigate potential discomfort. Objective: To determine if a physical training program could help during chemotherapy in a patient with LH. Methodology: This is a case study with a LH carrier individual who, during the course of chemotherapy with eight sessions every other week, underwent 16 weeks of physical training (non-linear periodization). We evaluated some physical abilities, and anthropometric parameters, hematological and WURSS 21 and DALDA surveys. To compare the results before and after physical training, the percentage change was used (Delta%). Results: After the training period, it was observed improvement of assessed physical, anthropometric maintenance and good hematological responses. It was also observed, few occurrences of symptoms of stress and immune fit the sources and symptoms of stress. Conclusions: The proposed physical training contributed to the patient during the treatment of chemotherapy while maintaining satisfactory hematological profile and improving some of their physical and mental conditions.
Institutions: Estácio (Brazil), Federal Institute of São Paulo
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2565068482
